Compare WVE & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | CIVI |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 2015 | 2011 |
| Metric | WVE | CIVI |
|---|---|---|
| Price | $15.74 | $27.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 13 |
| Target Price | $29.94 | ★ $40.80 |
| AVG Volume (30 Days) | ★ 13.7M | 1.4M |
| Earning Date | 11-10-2025 | 02-23-2026 |
| Dividend Yield | N/A | ★ 7.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.86 |
| Revenue | $109,230,000.00 | ★ $4,711,808,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.00 | N/A |
| P/E Ratio | ★ N/A | $4.05 |
| Revenue Growth | ★ 103.75 | N/A |
| 52 Week Low | $5.28 | $22.79 |
| 52 Week High | $21.73 | $55.35 |
| Indicator | WVE | CIVI |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 47.95 |
| Support Level | $15.23 | $26.51 |
| Resistance Level | $18.50 | $27.72 |
| Average True Range (ATR) | 1.18 | 0.88 |
| MACD | -0.34 | -0.05 |
| Stochastic Oscillator | 16.51 | 36.05 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.